Menée au Canada entre 2016 et 2018 auprès de 27 601 participants à un programme de sevrage tabagique mettant à disposition des substituts nicotiniques et un soutien psychologique, cette étude analyse les différences dans les caractéristiques du traitement ou les résultats entre les patients de sexe féminin et masculin

A comparison of quit outcomes for men and women in a smoking cessation program offering personalized nicotine replacement therapy and counselling in primary care clinics

Voci, Sabrina ; Veldhuizen, Scott ; Tien, Stephanie ; Barker, Megan ; Minian, Nadia ; Selby, Peter ; Zawertailo, Laurie

Women may have greater difficulty achieving long-term abstinence following a quit attempt compared to men. We sought to determine whether there were differences in treatment characteristics or outcome between female and male primary care patients enrolled in a smoking cessation program providing personalized nicotine replacement therapy (NRT) with counselling support.The sample included 27,601 Ontarians (53% female, 47% male) who enrolled in the Smoking Treatment for Ontario Patients program [...]

Menée en Suède auprès de 17 035 femmes (durée de suivi : 344 584 personnes-années), cette étude analyse l'association entre l'apport alimentaire ou le taux sérique de sélénium et le risque de cancer du sein (1 427 cas)

Risk of breast cancer in relation to dietary intake of selenium and serum selenium as a marker of dietary intake: a prospective cohort study within The Malmö Diet and Cancer Study

Bengtsson, Ylva ; Sandsveden, Malte ; Manjer, Jonas

Purpose: Selenium has been suggested to be protective against breast cancer, but the evidence remains inconclusive. Hence, it is important to further examine the potential protective effect. This prospective cohort study investigates pre-diagnostic selenium intake in relation to breast cancer risk. In addition, we analyze serum selenium as a marker of dietary intake. Methods: This study includes 17,035 women in the Malmö Diet and Cancer cohort. Dietary assessment and serum samples were [...]

Menée aux Etats-Unis à partir des données 2008-2018 d'une enquête, cette étude analyse les tendances du taux de vaccination contre le papillomavirus humain chez les enfants âgés de 9 à 12 ans, puis identifie des facteurs sociodémographiques associés au statut vaccinal

Trends in HPV Vaccination Initiation and Completion Within Ages 9–12 Years: 2008–2018

Chido-Amajuoyi, Onyema Greg ; Talluri, Rajesh ; Wonodi, Chizoba ; Shete, Sanjay

BACKGROUND AND OBJECTIVES: Routine human papillomavirus (HPV) vaccination is recommended at ages 11 to 12 years and may be initiated as early as 9 years of age. METHODS: Data were derived from the National Immunization Survey-Teen, spanning 2008–2018. Using health care provider–verified vaccination histories, we examined trends in human papillomavirus vaccination up-to-date (HPV-UTD) rates within ages 9 to 12 years. Furthermore, we assessed vaccination status by sociodemographic factors and US [...]

Menée à partir de données portant sur 110 participants, cette étude présente l'évaluation d'une formation sur le sevrage tabagique, destinée aux prestataires de soins en oncologie et adaptée aux besoins particuliers des patients fumeurs atteints d'un cancer

Training oncology care providers in the assessment and treatment of tobacco use and dependence

Ostroff, Jamie S. ; Bolutayo Gaffney, Kemi L. ; O’Brien, Maureen ; deLeon-Sanchez, Suhana T. ; Whitlock, C. Will ; Kotsen, Chris S. ; Carter-Harris, Lisa ; Banerjee, Smita C. ; Schofield, Elizabeth

BACKGROUND: Clinical practice guidelines for promoting smoking cessation in cancer care exist; however, most oncology settings have not established tobacco use assessment and treatment as standard care. Inadequate staff training and other implementation challenges have been identified as barriers for delivery of evidence-based tobacco treatment. Providing training in tobacco treatment tailored to the unique needs of tobacco-dependent patients with cancer is one strategy to improve adoption of [...]